Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-14

Clinical Trial Update: Whole Heart Radiotherapy for End-stage Heart Failure [Phase 1]

View source ↗

Summary

A Phase 1 trial is investigating whole-heart radiotherapy for end-stage heart failure. The study is currently enrolling by invitation and targets patients with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Heart Failure NYHA Class III, Heart Failure NYHA Class IV | Phase 1 | Status: ENROLLING_BY_INVITATION